CMS certification 460001
Intermountain Health Utah Valley Hospital
1034 North 500 West, Provo, UT 84604
Intermountain Health Utah Valley Hospital has a CMS overall rating of 5 out of 5 stars. 82% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on none. Emergency patients spend a median of 2 h 58 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,522 completed surveys, 27% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | UT | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 455 visits sampled · US median for EDs of the same volume: 3 h 22 min | 2 h 58 min | 2 h 13 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 31 visits sampled | 3 h 45 min | 3 h 25 min | 4 h 17 min |
| Left before being seen Lower is better · 49,164 patients | 1% | 1% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 13 patients | 38% | 69% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 137 patients | 74% | 68% | 65% |
How Intermountain Health Utah Valley Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Intermountain Health Utah Valley HospitalThis hospital | 5/5 | 82% | 2 h 58 min | 7 better |
| Mountain View HospitalSame county · Payson | 5/5 | 73% | 1 h 57 min | 3 better |
| Intermountain Health Spanish Fork HospitalSame county · Spanish Fork | Not rated | 80% | 2 h 32 min | 1 better |
| Orem Community HospitalSame county · Orem | Not rated | 85% | 1 h 42 min | No different |
| Timpanogos Regional HospitalSame county · Orem | 4/5 | 73% | 1 h 43 min | 2 better |
| American Fork HospitalSame county · American Fork | 4/5 | 76% | 2 h 22 min | 2 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Provo.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,010 cases | Too few cases | 3.9% | 3.9% |
| Heart attack 287 cases | Too few cases | 10.3% | 11.9% |
| Heart failure 339 cases | Too few cases | 12.3% | 11.1% |
| Pneumonia 332 cases | Too few cases | 15.3% | 15.2% |
| Stroke 491 cases | Too few cases | 12.3% | 11.9% |
| COPD 30 cases | Too few cases | 8.9% | 8.6% |
| Heart bypass surgery (CABG) 112 cases | Too few cases | 2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.77 likely 0.49 – 1.05 | 1 |
| After hip or knee replacement 81 cases | Too few cases | 4.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 127 cases | No different | 174.64 per 1,000 likely 130.79 per 1,000 – 218.48 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,751 cases | No different | 0.43 per 1,000 likely 0 per 1,000 – 1.03 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 6,015 cases | No different | 0.18 per 1,000 likely 0 per 1,000 – 0.37 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 6,148 cases | No different | 0.29 per 1,000 likely 0.09 per 1,000 – 0.48 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,100 cases | No different | 2.73 per 1,000 likely 1.36 per 1,000 – 4.11 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 949 cases | No different | 1.43 per 1,000 likely 0.02 per 1,000 – 2.84 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 914 cases | No different | 6.21 per 1,000 likely 0.74 per 1,000 – 11.68 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,266 cases | No different | 2.09 per 1,000 likely 0.29 per 1,000 – 3.88 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 920 cases | No different | 4.73 per 1,000 likely 1.43 per 1,000 – 8.04 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 465 cases | No different | 1.56 per 1,000 likely 0.12 per 1,000 – 3 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,217 cases | No different | 1.2 per 1,000 likely 0.27 per 1,000 – 2.13 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.18 likely 0.05 – 0.49 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.27 likely 0.09 – 0.66 | 1 |
| Surgical site infections after colon surgery | No different | 0.48 likely 0.08 – 1.58 | 1 |
| MRSA bloodstream infections | No different | 0.33 likely 0.06 – 1.1 | 1 |
| C. diff intestinal infections | Better | 0.25 likely 0.13 – 0.42 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 516 cases | Too few cases | 13.2% | 14.4% |
| Readmitted after heart failure 585 cases | Too few cases | 18.7% | 21.3% |
| Readmitted after pneumonia 530 cases | Too few cases | 15.7% | 17.3% |
| Readmitted after COPD 49 cases | Too few cases | 20.2% | 20% |
| Readmitted after heart bypass surgery 177 cases | Too few cases | 10.2% | 11% |
| Readmitted after hip or knee replacement 80 cases | Too few cases | 5.6% | 5.8% |
| Days back in hospital after a heart attack 342 cases | Too few cases | -22.3 days per 100 | — |
| Days back in hospital after heart failure 379 cases | Too few cases | -44.2 days per 100 | — |
| Days back in hospital after pneumonia 359 cases | Too few cases | -11.3 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 665 cases | No different | 14.5 per 1,000 likely 11 per 1,000 – 19.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 46 cases | No different | 10.7 per 100 likely 7.2 per 100 – 15.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 46 cases | No different | 5.1 per 100 likely 3.1 per 100 – 7.9 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 456 cases | No different | 1 likely 0.7 – 1.3 | — |
1 more measure had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $826,585
- 2020 $979,795
- 2021 $899,885
- 2022 $629,839
- 2023 $1M
- 2024 $1.2M
- 2025 $2.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $124,027 | 7 |
| Grants | $47,650 | 8 |
| Royalties and licensing fees | $38,847 | 12 |
| Space rental and facility fees | $8,650 | 5 |
| Consulting fees | $1,737 | 1 |
| Debt forgiveness | $740 | 1 |
| Medical devices and supplies on long-term loan | $700 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Eli Lilly and Company | $488,234 | 4 |
| AstraZeneca Pharmaceuticals LP | $322,932 | 2 |
| United Therapeutics Corporation | $313,743 | 108 |
| Abbott Laboratories | $186,736 | 25 |
| Boston Scientific Corporation | $170,072 | 25 |
| Intuitive Surgical Operations, Inc. | $107,530 | 7 |
| Novartis Pharmaceuticals Corporation | $101,745 | 5 |
| Jenavalve Technology, Inc. | $83,222 | 3 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCUL… Eli Lilly and Company · NCT06292013 | $322,792 |
| A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patient… AstraZeneca Pharmaceuticals LP | $189,364 |
| POSTMONARCH: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO COMPARE THE EFFICACY OF ABEMACICLIB PLUS FULVESTRANT TO PLACEBO PLUS FU… Eli Lilly and Company · NCT05169567 | $165,442 |
| A Phase III, Multicentre, Randomised, Double blind, Parallel group, Placebo controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI… AstraZeneca Pharmaceuticals LP | $133,568 |
| Ion registry study and IRB fees Intuitive Surgical Operations, Inc. | $107,530 |
| AVANT GUARD Boston Scientific Corporation · NCT06096337 | $99,705 |
| A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of Second Mitochondria… BeiGene, Ltd. · NCT05381909 | $98,776 |
| A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Prog… United Therapeutics Corporation · NCT05943535 | $97,610 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Intermountain Health Utah Valley Hospital
Is Intermountain Health Utah Valley Hospital a good hospital?
Intermountain Health Utah Valley Hospital has a CMS overall rating of 5 out of 5 stars. Of the 24 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 7 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Intermountain Health Utah Valley Hospital?
82% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,522 completed HCAHPS surveys.
How long is the wait in the Intermountain Health Utah Valley Hospital emergency room?
Emergency patients spend a median of 2 h 58 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Intermountain Health Utah Valley Hospital receive money from drug and device companies?
Drug and device makers reported $2.1M in payments to Intermountain Health Utah Valley Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.